QLIFE — Qlife Holding AB Share News
0.000.00%
Last trade - 00:00- SEK32.11m
- SEK36.10m
- SEK0.32m
Brief: Qlife Secures U.S. Patent Approval For Core Egoo
Brief: Qlife Completes Customer-Funded Feasibility Study
Sweden's Qlife Q2 revenue rises on pharma project
Brief: Qlife Q2 EBITDA SEK -4.72 Million
Advisory: Alerts on Qlife's agreement with global pharma company withdrawn
Brief: Qlife Holding Enters Feasibility Deal With Pharma Co For Egoo Health Biomarker
Brief: Qlife Holding Q1 EBITDA Loss SEK 5.5 Mln
Sweden's Qlife Q1 revenue drops, losses widen slightly
Brief: Qlife Holding Q4 EBITDA At SEK -1.6 Million
Brief: Qlife Holding Says Last Day Of Trading With BTA Is 8 April 2026
Brief: Qlife Announces Outcome Of Rights Issue, Resolves On Directed Issue
Brief: Qlife Says Hipro To Accelerate Egoo Development, Regulatory Approval In China
Brief: Qlife Publishes Information Document For SEK 31.4 Million Rights Issue
Brief: Qlife Launches Pharmacy Pilot Project In Nordic Markets
Brief: Qlife Holding To Hold EGM On Feb 26
Brief: Qlife Submits Egoo PHE For Regulatory Approval
Brief: Qlife Launches SEK 31.4 Mln Rights Issue
Brief: Egoo Health Says Breakthrough Precision In Diabetes Biomarker Test
Brief: Qlife, Hipro Sign Exclusive Commercial Agreement